• Dec 16, 2024

Grindr's Expanding LGBTQ+ Market and 20% Revenue Growth Impresses Goldman Sachs

Goldman Sachs analyst Eric Sheridan initiated coverage on Grindr Inc (NYSE:GRND) with a Buy rating and a price target of $20. Grindr is an online dating platform primarily focused on serving the LGBTQ+ community with 14.6 million monthly active users (as of the third quarter of 2024) globally. In this initiation, Sheridan framed his work around three key debates for Grindr stock, including the company’s addressable market, whether it achieves a 20%+ fiscal 2024-2029 revenue CAGR, and whether it

  • Dec 16, 2024

Bitcoin Tops $107K, MicroStrategy Buys More

Bitcoin broke another price record, rising above $107,000 Monday, after crossing $106,000 in late trading Sunday. Meanwhile, MicroStrategy, which calls itself a bitcoin treasury company, announced yet another $1.5 billion bitcoin purchase.

  • Dec 16, 2024

Why Is Playboy Owner PLBY Group Stock Rocketing Today?

PLBY Group, Inc. (NASDAQ:PLBY) shares rose following the announcement of an expanded partnership with Byborg Enterprises, which includes a commitment from Byborg to purchase an additional $25 million in equity. The collaboration includes finalizing a long-term, exclusive licensing agreement and signing a new securities purchase agreement with Byborg. As per the licensing deal, Byborg will license specific Playboy digital intellectual property and manage Playboy Plus, Playboy TV (both linear and

  • Dec 16, 2024

Bitcoin rallies past $107,000, hopes grow for strategic reserve

(Reuters) -Bitcoin's record rally topped $107,000 on Monday after President-elect Donald Trump reiterated that he plans to create a U.S. bitcoin strategic reserve similar to its strategic oil reserve, stoking the enthusiasm of crypto bulls. Investor sentiment also got a lift from the inclusion of MicroStrategy into the tech-heavy Nasdaq 100 index that will likely lead to more inflows for the software firm turned bitcoin buyer. Bitcoin, the world's biggest and best known cryptocurrency, extended gains to a session high of $107,148 and was most recently at $106,877, up 5.43% from late Friday.

  • Dec 16, 2024

Why Is Larimar Therapeutics Stock Trading Lower On Monday?

On Monday, Larimar Therapeutics, Inc. (NASDAQ:LRMR) released initial data from the ongoing long-term OLE study evaluating daily subcutaneous injections of 25 mg of nomlabofusp self-administered or administered by a caregiver in participants with Friedreich’s Ataxia. Friedreich’s Ataxia is caused by a mutation in the FXN gene, which carries the code for the frataxin protein. Frataxin is important for the normal function of mitochondria, the energy-producing parts of cells At the time of data cut